Log In
Print
BCIQ
Print
Print this Print this
 

BL-1020 (formerly CYP-1020)

  Manage Alerts
Collapse Summary General Information
Company BioLineRx Ltd.
DescriptionGABA enhanced antipsychotic agent
Molecular Target GABA A receptor ; Dopamine receptor
Mechanism of ActionDopamine receptor antagonist; GABA A receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today